益生菌用于重度急性胰腺炎治疗的Meta分析

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (622 KB)
输出: BibTeX | EndNote (RIS)

摘要目的用Meta分析的方法评价益生菌用于治疗重度急性胰腺炎(severe acute pancreatitis, SAP)的效果。方法检索PubMed、The Cochrane Library、中国生物医学文献数据库(CBM)、中文科技期刊数据库(维普),中国期刊全文数据库(CNKI),万方学术期刊全文数据库,全面查找益生菌治疗SAP的文献,评价纳入文献的方法学质量,用RevMan5.0软件统计分析。结果共纳入7篇文献,共有SAP患者654例,Meta分析结果显示实验组与对照组在病死率(RR=1.29, 95% CI:0.77~2.16,P=0.33)、多器官衰竭发生率(RR=0.81, 95%CI:0.52~1.24,P=0.33)、感染性并发症发生率(RR=0.72, 95%CI:0.37~1.39,P=0.33)及抗生素使用率(RR=0.89, 95% CI:0.71~1.10,P=0.28)方面均无统计学差异,但在胰腺脓肿发生率(RR=0.53, 95% CI:0.28~0.98,P=0.04)方面存在统计学差异。结论益生菌不能降低SAP患者感染性并发症发生率、多器官衰竭发生率、抗生素使用率和病死率,但可能降低胰腺脓肿发生率。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	牛天天
	唐红卫

关键词 ：益生菌, 重度急性胰腺炎, 疗效, mete分析

Abstract：Objective To use method of the meta-analysis for evaluating efficacy of probiotics applied to severe acute pancreatitis. Methods The PubMed, The Cochrane Library, CBM database, VIP database, CNKI database, and Wanfang database were searched, comprehensive literature search of the probiotics usage in the treatment of severe acute pancreatitis, and the methodological quality of literatures was evaluated. RevMan 5.0 software was used to conduct statistics and analysis. Results The study participants included 7 articles, a total of 654 patients with severe acute pancreatitis. There were no statistically significant differences in mortality (RR=1.29, 95%CI:0.77-2.16,P=0.33), multiple organ failure incidence (RR=0.81, 95%CI:0.52-1.24,P=0.33), infectious complications incidence(RR=0.72, 95%CI:0.37-1.39,P=0.33)and antibiotics usage(RR=0.89, 95% CI:0.71-1.10,P=0.28)between experimental group and control group. But there was significant statistical difference in pancreatic abscess incidence(RR=0.53, 95%CI:0.28-0.98,P=0.04). Conclusions According to the current research data, probiotics in SAP patients have no positive effects on mortality,multiple organ failure incidence, infectious complications incidence and antibiotics usage. But they can reduce the incidence of pancreatic abscess.

Key words： probiotics severe acute pancreatitis efficacy meta analysis

收稿日期: 2015-01-20

ZTFLH:

R576

通讯作者: 唐红卫,E-mail:thwwjp@hotmail.com

作者简介: 牛天天,硕士研究生,E-mail:niuttian@163.com

引用本文:

牛天天, 唐红卫. 益生菌用于重度急性胰腺炎治疗的Meta分析[J]. 武警医学, 2015, 26(6): 576-579. NIU Tiantian, TANG Hongwei. Meta-analysis of efficacy of probiotics for severe acute pancreatitis. Med. J. Chin. Peop. Armed Poli. Forc., 2015, 26(6): 576-579.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2015/V26/I6/576

[2]	Capurso G, Zerboni G, Signoretti M, et al. Role of the gut barrier in acute pancreatitis[J]. J Clin Gastroenterol, 2012, 46(Suppl N):S46-S51.
[1]	中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南(2013,上海)[J]. 中国实用内科杂志,2013,33(7):530-535.
[3]	Jafri N S, Mahid S S, Idstein S R, et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systemetic review and meta-analysis [J]. Am J Surg, 2009,197(6):806-813.
[4]	Dellinger EP,Tellado JM,Soto NE,et al.Early antibiotic treatment for severe acute necrotizing pancreatitis:a randomized, double-blind,placebo controlled study [J]. Ann Surg, 2007,245(5):674-683.
[2]	Capurso G, Zerboni G, Signoretti M, et al. Role of the gut barrier in acute pancreatitis[J]. J Clin Gastroenterol, 2012, 46(Suppl N):S46-S51.
[3]	Jafri N S, Mahid S S, Idstein S R, et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systemetic review and meta-analysis [J]. Am J Surg, 2009,197(6):806-813.
[5]	陈春雷,李兰娟. 感染微生态学的研究进展[J]. 国外医学·流行病学传染病学分册,2005,32(5):271-273.
[4]	Dellinger EP,Tellado JM,Soto NE,et al.Early antibiotic treatment for severe acute necrotizing pancreatitis:a randomized, double-blind,placebo controlled study [J]. Ann Surg, 2007,245(5):674-683.
[5]	陈春雷,李兰娟. 感染微生态学的研究进展[J]. 国外医学·流行病学传染病学分册,2005,32(5):271-273.
[6]	Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J]. Gastroenterol Hepatol, 2014,11(8):506-514.
[6]	Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J]. Gastroenterol Hepatol, 2014,11(8):506-514.
[7]	Oláh A, Belágyi T, Issekutz A, et al. Randomized clinical trial of specific lactobacillus and fiber supplement to early enteral nutrition in patients with acute pancreatitis[J]. Br J Surg, 2002,89(9):1103-1107.
[7]	Oláh A, Belágyi T, Issekutz A, et al. Randomized clinical trial of specific lactobacillus and fiber supplement to early enteral nutrition in patients with acute pancreatitis[J]. Br J Surg, 2002,89(9):1103-1107.
[8]	Oláh A, Belágyi T, Pótó L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis:a prospective,randomized, double blind study[J]. Hepato-Gastroenterol, 2007,54(74):590-594.
[9]	Karakan T, Ergun M, Dogan I, et al. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: A prospective randomized double-blind study[J]. World J Gastroenterol, 2007,13(19):2733-2737.
[8]	Oláh A, Belágyi T, Pótó L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis:a prospective,randomized, double blind study[J]. Hepato-Gastroenterol, 2007,54(74):590-594.
[9]	Karakan T, Ergun M, Dogan I, et al. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: A prospective randomized double-blind study[J]. World J Gastroenterol, 2007,13(19):2733-2737.
[10]	Besselink M G, van Santvoort H C, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised,double-blind,placebo-controlled trial[J]. Lancet, 2008,371(9613):651-659.
[10]	Besselink M G, van Santvoort H C, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised,double-blind,placebo-controlled trial[J]. Lancet, 2008,371(9613):651-659.
[11]	周家德. 益生菌联合早期肠内营养治疗重症急性胰腺炎疗效观察[J]. 现代医院, 2012,12(5):70-71.
[11]	周家德. 益生菌联合早期肠内营养治疗重症急性胰腺炎疗效观察[J]. 现代医院, 2012,12(5):70-71.
[12]	Wang G, Wen J, Xu L, et al. Effect of enteral nutrition and ecoimmunonutrition on bacterial translocation and cytokine production in patients with severe acute pancreatitis[J]. J Surg Res, 2013,183(2):592-597.
[12]	Wang G, Wen J, Xu L, et al. Effect of enteral nutrition and ecoimmunonutrition on bacterial translocation and cytokine production in patients with severe acute pancreatitis[J]. J Surg Res, 2013,183(2):592-597.
[13]	崔立红,王晓辉,彭丽华,等. 早期肠内营养加微生态制剂对重症急性胰腺炎患者疗效的影响[J]. 中华危重病急救医学,2013,25(4):224-228.
[13]	崔立红,王晓辉,彭丽华,等. 早期肠内营养加微生态制剂对重症急性胰腺炎患者疗效的影响[J]. 中华危重病急救医学,2013,25(4):224-228.
[14]	Sand J, Nordback I. Probiotics in severe acute pancreatitis [J]. Lancet,2008,371(9613):634-635.
[14]	Sand J, Nordback I. Probiotics in severe acute pancreatitis [J]. Lancet,2008,371(9613):634-635.
[15]	Thomson A, Subramaniam K, Davies A. Nutritional therapy in acute pancreatitis--time to take stock [J]. Nutrition, 2012,28(7-8):731-732.
[15]	Thomson A, Subramaniam K, Davies A. Nutritional therapy in acute pancreatitis--time to take stock [J]. Nutrition, 2012,28(7-8):731-732.
[16]	AiSamaraee A, McCallum I J, Coyne P E, et al. Nutritional strategies in severe acute pancreatitis: a systematic review of the evidence[J].Surgeon,2010,8(2):105-110.
[16]	AiSamaraee A, McCallum I J, Coyne P E, et al. Nutritional strategies in severe acute pancreatitis: a systematic review of the evidence[J].Surgeon,2010,8(2):105-110.
[17]	Meier R, Steuerwald M. Place of probiotics [J].Curr Opin Crit Care, 2005,11(4):318-325.
[17]	Meier R, Steuerwald M. Place of probiotics [J].Curr Opin Crit Care, 2005,11(4):318-325.
[18]	Tellado M J. Prevention of infection following severe acute pancreatitis [J]. Curr Opin Crit Care, 2007,13(4):416-420.
[18]	Tellado M J. Prevention of infection following severe acute pancreatitis [J]. Curr Opin Crit Care, 2007,13(4):416-420.
[19]	Oláh A1, Romics Jr L. Enteral nutrition in acute pancreatitis: a review of the current evidence[J]. World J Gastroenterol, 2014,20(43):16123-16131.
[19]	Oláh A1, Romics Jr L. Enteral nutrition in acute pancreatitis: a review of the current evidence[J]. World J Gastroenterol, 2014,20(43):16123-16131.
[20]	Capurso G, Marignani M, Piciucchi M, et al. Probiotics and severe acute pancreatitis[J]. J Clin Gastroenterol, 2008,42(Supp1 3 PN):S152-S153.
[21]	Gou S,Yang Z,Liu T,et al. Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials[J]. Crit Care,2014,18(2):R57.
[20]	Capurso G, Marignani M, Piciucchi M, et al. Probiotics and severe acute pancreatitis[J]. J Clin Gastroenterol, 2008,42(Supp1 3 PN):S152-S153.
[22]	Besselink M G,van Santvoort H C, Renooij W, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis[J]. Ann Surg, 2009,250(5):712-719.
[21]	Gou S,Yang Z,Liu T,et al. Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials[J]. Crit Care,2014,18(2):R57.
[22]	Besselink M G,van Santvoort H C, Renooij W, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis[J]. Ann Surg, 2009,250(5):712-719.